{"transactions":[{"id":3181770,"issuer":{"id":4388,"kind":"organization","name":"Kodiak Sciences Inc."},"owners":[{"id":149989,"kind":"person","name":"Liang Hong","position":1,"cik":"0001754627","reported_name":"Liang Hong","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Discovery Medicine"}}],"security":"Common Stock","published_at":"2020-04-07T00:08:54.000Z","date":"2020-04-02","kind":"sale","acquired":false,"shares":4000,"price":42.34,"value":169360.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted-average price.  The shares were sold in multiple transactions ranging from $41.97 to $42.71, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":130166,"source":{"system":"sec-edgar","filing":"0001209191-20-023673","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468748/000120919120023673/doc4.xml","form_type":"4"}},{"id":3192103,"issuer":{"id":4388,"kind":"organization","name":"Kodiak Sciences Inc."},"owners":[{"id":149989,"kind":"person","name":"Liang Hong","position":1,"cik":"0001754627","reported_name":"Liang Hong","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Discovery Medicine"}}],"security":"Common Stock","published_at":"2020-03-30T20:51:55.000Z","date":"2020-03-26","kind":"sale","acquired":false,"shares":352,"price":49,"value":17248.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a 10b5-1 trading plan."}],"balance_after":134166,"source":{"system":"sec-edgar","filing":"0001209191-20-021727","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1468748/000120919120021727/doc4.xml","form_type":"4"}},{"id":3192102,"issuer":{"id":4388,"kind":"organization","name":"Kodiak Sciences Inc."},"owners":[{"id":149989,"kind":"person","name":"Liang Hong","position":1,"cik":"0001754627","reported_name":"Liang Hong","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Discovery Medicine"}}],"security":"Common Stock","published_at":"2020-03-30T20:51:55.000Z","date":"2020-03-26","kind":"sale","acquired":false,"shares":1103,"price":48.5348,"value":53533.8844,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted-average price.  The shares were sold in multiple transactions ranging from $47.88 to $48.78, inclusive."}],"balance_after":134518,"source":{"system":"sec-edgar","filing":"0001209191-20-021727","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1468748/000120919120021727/doc4.xml","form_type":"4"}},{"id":3192101,"issuer":{"id":4388,"kind":"organization","name":"Kodiak Sciences Inc."},"owners":[{"id":149989,"kind":"person","name":"Liang Hong","position":1,"cik":"0001754627","reported_name":"Liang Hong","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Discovery Medicine"}}],"security":"Common Stock","published_at":"2020-03-30T20:51:55.000Z","date":"2020-03-26","kind":"sale","acquired":false,"shares":2545,"price":47.281,"value":120330.145,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted-average price.  The shares were sold in multiple transactions ranging from $46.84 to $47.84, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes."}],"balance_after":135621,"source":{"system":"sec-edgar","filing":"0001209191-20-021727","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468748/000120919120021727/doc4.xml","form_type":"4"}},{"id":3197890,"issuer":{"id":4388,"kind":"organization","name":"Kodiak Sciences Inc."},"owners":[{"id":149989,"kind":"person","name":"Liang Hong","position":1,"cik":"0001754627","reported_name":"Liang Hong","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Discovery Medicine"}}],"security":"Common Stock","published_at":"2020-03-23T20:36:38.000Z","date":"2020-03-19","kind":"sale","acquired":false,"shares":2046,"price":39.99,"value":81819.54,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted-average price.  The shares were sold in multiple transactions ranging from $39.77 to $40.12, inclusive."}],"balance_after":138166,"source":{"system":"sec-edgar","filing":"0001209191-20-020648","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1468748/000120919120020648/doc4.xml","form_type":"4"}},{"id":3197889,"issuer":{"id":4388,"kind":"organization","name":"Kodiak Sciences Inc."},"owners":[{"id":149989,"kind":"person","name":"Liang Hong","position":1,"cik":"0001754627","reported_name":"Liang Hong","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Discovery Medicine"}}],"security":"Common Stock","published_at":"2020-03-23T20:36:38.000Z","date":"2020-03-19","kind":"sale","acquired":false,"shares":1954,"price":38.89,"value":75991.06,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted-average price.  The shares were sold in multiple transactions ranging from $38.61 to $39.50, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set fort in these footnotes."}],"balance_after":140212,"source":{"system":"sec-edgar","filing":"0001209191-20-020648","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468748/000120919120020648/doc4.xml","form_type":"4"}},{"id":3327090,"issuer":{"id":4388,"kind":"organization","name":"Kodiak Sciences Inc."},"owners":[{"id":149989,"kind":"person","name":"Liang Hong","position":1,"cik":"0001754627","reported_name":"Liang Hong","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Discovery Medicine"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-02T22:32:40.000Z","date":"2019-12-30","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option will vest on January 30, 2020, and 1/48th of the shares subject to the option vest on the same day of each month thereafter, subject to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) as of each such date."}],"balance_after":50000,"derivative":{"exercise_price":73.51,"expiration_date":"2029-12-29","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-20-000404","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468748/000120919120000404/doc4.xml","form_type":"4"}},{"id":3352506,"issuer":{"id":4388,"kind":"organization","name":"Kodiak Sciences Inc."},"owners":[{"id":149989,"kind":"person","name":"Liang Hong","position":1,"cik":"0001754627","reported_name":"Liang Hong","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Discovery Medicine"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-12-04T22:33:35.000Z","date":"2019-12-02","kind":"exercise","acquired":false,"shares":12916,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-forty-eighth of the shares subject to the option vested on May 15, 2017, and 1/48th of the shares subject to the option vest on the same day of each month thereafter."}],"balance_after":7084,"derivative":{"exercise_price":1.06,"expiration_date":"2027-05-16","underlying":"Common Stock","underlying_shares":12916},"source":{"system":"sec-edgar","filing":"0001209191-19-059119","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1468748/000120919119059119/doc4.xml","form_type":"4"}},{"id":3352505,"issuer":{"id":4388,"kind":"organization","name":"Kodiak Sciences Inc."},"owners":[{"id":149989,"kind":"person","name":"Liang Hong","position":1,"cik":"0001754627","reported_name":"Liang Hong","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Discovery Medicine"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-12-04T22:33:35.000Z","date":"2019-12-02","kind":"exercise","acquired":false,"shares":29250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-Five percent of the shares subject to the option vested on December 7, 2016, and 1/48th of the shares subject to the option vest on the same day of each month thereafter."}],"balance_after":2750,"derivative":{"exercise_price":1.04,"expiration_date":"2026-06-23","underlying":"Common Stock","underlying_shares":29250},"source":{"system":"sec-edgar","filing":"0001209191-19-059119","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1468748/000120919119059119/doc4.xml","form_type":"4"}},{"id":3352504,"issuer":{"id":4388,"kind":"organization","name":"Kodiak Sciences Inc."},"owners":[{"id":149989,"kind":"person","name":"Liang Hong","position":1,"cik":"0001754627","reported_name":"Liang Hong","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Discovery Medicine"}}],"security":"Common Stock","published_at":"2019-12-04T22:33:35.000Z","date":"2019-12-02","kind":"exercise","acquired":true,"shares":12916,"price":1.06,"value":13690.96,"ownership":{"direct":true},"balance_after":142166,"source":{"system":"sec-edgar","filing":"0001209191-19-059119","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1468748/000120919119059119/doc4.xml","form_type":"4"}},{"id":3352503,"issuer":{"id":4388,"kind":"organization","name":"Kodiak Sciences Inc."},"owners":[{"id":149989,"kind":"person","name":"Liang Hong","position":1,"cik":"0001754627","reported_name":"Liang Hong","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Discovery Medicine"}}],"security":"Common Stock","published_at":"2019-12-04T22:33:35.000Z","date":"2019-12-02","kind":"exercise","acquired":true,"shares":29250,"price":1.04,"value":30420.0,"ownership":{"direct":true},"balance_after":129250,"source":{"system":"sec-edgar","filing":"0001209191-19-059119","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468748/000120919119059119/doc4.xml","form_type":"4"}},{"id":3459175,"issuer":{"id":4388,"kind":"organization","name":"Kodiak Sciences Inc."},"owners":[{"id":149989,"kind":"person","name":"Liang Hong","position":1,"cik":"0001754627","reported_name":"Liang Hong","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-07-18T21:49:52.000Z","date":"2019-07-16","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One forty-eighth of the shares subject to the option will vest on August 16, 2019, and 1/48th of the shares subject to the option vest on the same day of each month thereafter, subject to the Reporting Person's continuous service as a service provider on each such date."}],"balance_after":40000,"derivative":{"exercise_price":14.23,"expiration_date":"2029-07-15","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0000899243-19-019935","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468748/000089924319019935/doc4.xml","form_type":"4"}},{"id":3668043,"issuer":{"id":4388,"kind":"organization","name":"Kodiak Sciences Inc."},"owners":[{"id":149989,"kind":"person","name":"Liang Hong","position":1,"cik":"0001754627","reported_name":"Liang Hong","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-02-08T21:15:29.000Z","date":"2019-02-07","kind":"exercise","acquired":false,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Reporting Person was originally granted an option to purchase 132,000 shares. Twenty-Five percent of the shares subject to the option vested on December 7, 2016, and 1/48th of the shares subject to the option vest on the same day of each month thereafter. On August 30, 2018, the Reporting Person exercised 20,000 of those shares and on February 7, 2019, the Reporting Person exercised 80,000 of those shares."}],"balance_after":32000,"derivative":{"exercise_price":1.04,"expiration_date":"2026-06-23","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0000899243-19-003022","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1468748/000089924319003022/doc4.xml","form_type":"4"}},{"id":3668042,"issuer":{"id":4388,"kind":"organization","name":"Kodiak Sciences Inc."},"owners":[{"id":149989,"kind":"person","name":"Liang Hong","position":1,"cik":"0001754627","reported_name":"Liang Hong","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2019-02-08T21:15:29.000Z","date":"2019-02-07","kind":"exercise","acquired":true,"shares":80000,"price":1.04,"value":83200.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person entered into a Lock-up Agreement in favor of the underwriters of the Company's initial public offering in October 2018 (the \"Lock-up\"). The terms of the Lock-up permit the exercise of options by the Reporting Person for cash and the shares of common stock issued as a result of the exercise are subject to the terms of the Lock-up.  No shares of common stock were sold by the Reporting Person in connection with the exercise."}],"balance_after":100000,"source":{"system":"sec-edgar","filing":"0000899243-19-003022","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468748/000089924319003022/doc4.xml","form_type":"4"}},{"id":3795957,"issuer":{"id":4388,"kind":"organization","name":"Kodiak Sciences Inc."},"owners":[{"id":149989,"kind":"person","name":"Liang Hong","position":1,"cik":"0001754627","reported_name":"Liang Hong","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-10-05T21:32:15.000Z","date":"2018-10-03","kind":"grant","acquired":true,"shares":69820,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-sixtieth of the shares subject to the option will vest on November 3, 2018, and 1/60th of the shares subject to the option vest on the same day of each month thereafter."}],"balance_after":69820,"derivative":{"exercise_price":10,"expiration_date":"2028-10-02","underlying":"Common Stock","underlying_shares":69820},"source":{"system":"sec-edgar","filing":"0000899243-18-026321","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468748/000089924318026321/doc4.xml","form_type":"4"}}]}